Skip to content

Leukemia & Lymphoma

Font Size

Childhood Non-Hodgkin Lymphoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (06 / 06 / 2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Childhood Non-Hodgkin Lymphoma (NHL)

Recommended Related to Leukemia & Lymphoma

Singer Diana Krall Fundraises for Leukemia

Listen to Diana Krall’s new album, Quiet Nights, and you may think you’ve been transported to a hot steamy night in Brazil. And we do mean hot. “This album brings new excitement into what I’m doing,” Krall says. The chanteuse recently had a chance to debut a track from her 12th album, which hit stores in March, at a gala fundraiser in February, where she performed with her husband, Elvis Costello, as well as friends James Taylor, Elton John, and Sarah McLachlan. It was Krall’s seventh performance...

Read the Singer Diana Krall Fundraises for Leukemia article > >

Added Williams et al. as reference 30.

Added text to state that the Berlin-Frankfurt-Munster group reported that in pediatric patients with T-cell lymphoblastic lymphoma, loss of heterozygosity at chromosome 6q was observed in 12% of patients and was associated with unfavorable prognosis. NOTCH1 mutations were seen in 60% of patients and were associated with favorable prognosis; NOTCH1 mutations were rarely seen in patients with loss of heterozygosity in 6q16 (cited Bonn et al. as reference 34).

Cellular Classification of Childhood NHL

Added text to state that one study suggested that for children with stage I disease who had a complete resection, a "watch and wait" approach without chemotherapy may be indicated (cited Attarbaschi et al. as reference 54). Also added text to state that patients with higher-stage disease also had a favorable outcome with low- and intermediate-intensity chemotherapy with 94% event-free survival and 100% overall survival, with a 2-year median follow-up; it appears that BCL2-rearrangement negativity and high proliferative index predict favorable disease.

Added Yoon et al. as reference 65.

Treatment Option Overview

Added Galardy et al. as reference 17.

Added text to state that data support that positron emission tomography identifies more abnormalities than computed tomography scanning, but it is unclear whether this should be used to change therapy (cited Cheng et al. as reference 23).

Low-Stage Childhood NHL Treatment

Added text to state that although outcome is generally very good, treatments range from surgery only to multiagent chemotherapy and even autologous blood or marrow transplant. It appears that for pediatric patients without the BCL2 rearrangement and a high proliferative index, surgical resection with no further treatment is sufficient for completely resected, localized disease. For those with tumors that have the BCL2 rearrangement, treatment like that of adult patients with follicular lymphoma is preferred (cited Attarbaschi et. al. as reference 20).

High-Stage Childhood B-cell NHL Treatment

    1|2
    Next Article:

    Today on WebMD

    stem cells
    What are they and why do we need them?
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Do you know the symptoms?
     
    Vitamin D
    SLIDESHOW
    New Treatments For Non-Hodgkins Lymphoma
    FEATURE
     
    Lifestyle Tips for Depression Slideshow
    SLIDESHOW
    Pets Improve Your Health
    SLIDESHOW